To study the role of CIP2A in prostate cancer, we first investigated the expression and androgen regulation of this gene in clinical tissue samples, prostate cancer cell lines and different cell populations from benign prostate hypertrophy (BPH), HN-PC and CRPC patient samples. The gene discussed is CIP2A; the disease is prostate cancer.